Shypd.aiThe largest open index of AI toolsMeddenovo Drug Design is a Pharma & Biotech tool that uses AI to design cyclic peptides. It enables the discovery of next-generation peptide therapeutics for challenging targets.
Trending
Also listed in
About
Meddenovo Drug Design is a Lyon-based biotech company specializing in AI-powered, nature-inspired cyclic peptide design. Their platform, Mexa, combines large-scale AI-driven generation with physics-based evaluation and refinement to explore millions of candidate peptides per target. This technology allows for de novo drug design even without prior experimental data, accelerating hit identification in drug discovery. Meddenovo focuses on reducing early discovery risk and unlocking peptide-based modalities for difficult targets, particularly in oncology, radiopharmaceuticals, and metabolic diseases. Their approach leverages the unique properties of cyclic peptides, which bridge small molecules and biologics, offering structural rigidity for selective target binding and versatility for complex biological interfaces.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check meddenovo.com for current pricing.
FAQs
Trending
